DEUTSCHE BANK AG\ - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 60 filers reported holding APTEVO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$0
-100.0%
10
-100.0%
0.00%
Q1 2019$64,000
-84.7%
71,600
-78.3%
0.00%
Q4 2018$419,000
-56.1%
330,200
+75.8%
0.00%
Q3 2018$954,000
+31.6%
187,800
+29.2%
0.00%
Q2 2018$725,000145,400
+159680.2%
0.00%
Q1 2018$0
-100.0%
91
-94.3%
0.00%
Q4 2017$6,000
-81.2%
1,591
-88.7%
0.00%
Q3 2017$32,000
+700.0%
14,078
+575.9%
0.00%
Q2 2017$4,000
-50.0%
2,083
-47.6%
0.00%
Q1 2017$8,000
-61.9%
3,976
-57.3%
0.00%
Q4 2016$21,000
-91.0%
9,302
-89.9%
0.00%
Q3 2016$233,00092,2010.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 974,492$2,495,0000.55%
Perceptive Advisors 988,133$2,530,0000.16%
STRATEGIC INVESTMENT MANAGEMENT, LLC 38,860$99,0000.07%
Laurel Wealth Advisors, Inc. 42,890$110,0000.05%
CSS LLC/IL 353,977$906,0000.04%
GLG Partners LP 396,486$1,015,0000.03%
Capital Impact Advisors, LLC 12,318$32,0000.01%
Spark Investment Management LLC 66,000$168,0000.01%
Peak Asset Management, LLC 10,000$26,0000.01%
OXFORD ASSET MANAGEMENT LLP 99,390$254,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders